Orwa Aboud, Ph.D. - Publications

Affiliations: 
2013 Neurobiology and Developmental Science University of Arkansas for Medical Sciences, United States 
Area:
Neuroscience Biology, Genetics

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rowe L, Vera E, Acquaye A, Crandon S, Shah V, Bryla C, Wu J, Wall K, Siegel C, Reyes J, Penas-Prado M, Leggiero N, Cordova C, Burton E, Antony R, ... ... Aboud O, et al. The prevalence of altered body image in patients with primary brain tumors: an understudied population. Journal of Neuro-Oncology. PMID 32096067 DOI: 10.1007/S11060-020-03433-8  0.377
2019 Siegel C, Raygada M, Acquaye A, Stearn S, Wall K, Crandon S, Stevens-Brown K, Wu J, Vera L, Theeler B, Reyes J, Leggiero N, Cordova C, Bryla C, Burton E, ... ... Aboud O, et al. RARE-10. IMPROVING CARE FOR ADULT PATIENTS WITH RARE CNS TUMORS: THE NATIONAL CANCER INSTITUTE-COMPREHENSIVE ONCOLOGY NETWORK EVALUATING RARE CNS TUMORS (NCI-CONNECT) PROGRAM AND CLINIC Neuro-Oncology. 21: vi223-vi223. DOI: 10.1093/Neuonc/Noz175.933  0.383
2019 King A, Shuboni-Mulligan D, Vera E, Crandon S, Aboud O, Antony R, Boris L, Bryla C, Burton E, Cordova C, Gartland C, Grajkowska E, Penas-Prado M, Reyes J, Leggiero N, et al. QOLP-36. THE IMPORTANCE OF SLEEP DISTURBANCE IN PRIMARY BRAIN TUMOR (PBT) PATIENTS: CLINICAL CHARACTERISTICS & CO-OCCURRENCE WITH TUMOR-RELATED & PSYCHOLOGICAL SYMPTOMS Neuro-Oncology. 21: vi205-vi206. DOI: 10.1093/Neuonc/Noz175.856  0.34
2019 Aboud O, Gilbert M, Armstrong T, Vera E, Wu J, Wall K, Theeler B, Siegel C, Reyes J, Leggiero N, Crandon S, Cordova C, Boris L, Bryla C, Burton E, et al. NIMG-32. CHALLENGES OF IMAGING INTERPRETATION TO PREDICT OLIGODENDROGLIOMA GRADE Neuro-Oncology. 21: vi168-vi168. DOI: 10.1093/Neuonc/Noz175.702  0.303
2019 Vera E, Gilbert M, Aboud O, Antony R, Boris L, Bryla C, Burton E, Cordova C, Crandon S, Leggiero N, Penas-Prado M, Reyes J, Siegel C, Theeler B, Wall K, et al. HOUT-22. EVALUATING CLINICAL IMPACT UTILIZING THE RANO-PRO COLLABORATIVE’S STANDARDIZED PRIORITY CONSTRUCTS Neuro-Oncology. 21: vi116-vi117. DOI: 10.1093/Neuonc/Noz175.487  0.338
2019 Vyas Y, Vera E, Bryla C, Crandon S, Wu J, Wall K, Theeler B, Siegel C, Reyes J, Penas-Prado M, Leggiero N, Cordova C, Burton E, Antony R, Boris L, ... Aboud O, et al. HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS Neuro-Oncology. 21: vi112-vi112. DOI: 10.1093/Neuonc/Noz175.469  0.406
2018 Aboud O, Raffeld M, Brown J, Sabersky A, Briceno N, Brown M, Chung H, Crandon S, Ji M, Levine J, Patel S, Reyes J, Siegel C, Vera E, Xi L, et al. RARE-26. MUTATIONS IN MAPK PATHWAY GENES ARE CHARACTERISTIC AND CONFIRMATORY OF MULTINODULAR AND VACUOLATING NEURONAL TUMOR OF THE CEREBRUM Neuro-Oncology. 20: vi241-vi241. DOI: 10.1093/Neuonc/Noy148.999  0.333
2018 Acquaye A, Vera E, Aboud O, Armstrong T, Boris L, Brown M, Crandon S, Garren N, Ji M, Levine J, Romo C, Reyes J, Siegel C, Wu J, Mackey M, et al. QOLP-16. CAPTURING THE PRIMARY BRAIN TUMOR (PBT) PATIENT’S EXPERIENCE OF BODY IMAGE DISSATISFACTION: REPORT FROM THE NEURO-ONCOLOGY BRANCH-NATURAL HISTORY STUDY (NOB-NHS) Neuro-Oncology. 20: vi217-vi218. DOI: 10.1093/Neuonc/Noy148.902  0.355
2018 Mathen P, Armstrong T, Vera E, Acquaye A, Crandon S, Fletcher Ruiz M, Aboud O, Boris L, Brown M, Garren N, Ji M, Levine J, Mackey M, Romo C, Reyes J, et al. QOLP-09. ASSOCIATION BETWEEN BODY IMAGE INVESTMENT AND ALTERATION IN PATIENTS WITH PRIMARY BRAIN TUMORS Neuro-Oncology. 20: vi216-vi216. DOI: 10.1093/Neuonc/Noy148.895  0.375
2018 Rowe L, Vera E, Acquaye A, Crandon S, Fletcher Ruiz M, Aboud O, Boris L, Brown M, Garren N, Ji M, Levine J, Mackey M, Mathan P, Romo C, Reyes J, et al. QOLP-06. BODY IMAGE DISTURBANCE IN PATIENTS WITH PRIMARY BRAIN TUMORS Neuro-Oncology. 20: vi215-vi215. DOI: 10.1093/Neuonc/Noy148.892  0.37
2018 Siegel C, Aboud O, Brown M, Chung H, Raffeld M, Crandon S, Ji M, Levine J, Vera E, Patel S, Reyes J, Armstrong T, Xi L, Acquaye A, Boris L, et al. PATH-52. UTILIZING NEXT GENERATION SEQUENCING REPORTS IN CLINICAL DECISION MAKING: REPORT FROM THE NATIONAL INSTITUTES OF HEALTH (NIH) NEURO-ONCOLOGY BRANCH (NOB) NATURAL HISTORY STUDY (NHS) PRIMARY BRAIN TUMOR PANEL (PBTP) Neuro-Oncology. 20: vi170-vi170. DOI: 10.1093/Neuonc/Noy148.706  0.313
2018 Briceno N, Crandon S, Vera E, Siegel C, Aboud O, Brown M, Chung H, Ji M, Levine J, Patel S, Reyes J, Raffeld M, Gilbert M, Xi L, Armstrong T. INNV-43. NUCLEIC ACID ADEQUACY FROM ARCHIVED FORMALIN-FIXED PARAFFIN EMBEDDED (FFPE) TUMOR TISSUE FOR NEXT-GENERATION SEQUENCING (NGS) IN NATIONAL CANCER INSTITUTE (NCI)- NATURAL HISTORY STUDY (NHS) OF PRIMARY CNS TUMOR Neuro-Oncology. 20: vi146-vi146. DOI: 10.1093/Neuonc/Noy148.611  0.313
2018 Crandon S, Vera E, Acquaye A, Siegel C, Aboud O, Boris L, Brown M, Garren N, Ji M, Levine J, Romo C, Reyes J, Wu J, Gilbert M, Armstrong T. HOUT-12. CHARACTERIZATION OF SYMPTOM BURDEN IN MINORITY PATIENTS WITH CNS TUMORS: A REPORT FROM THE NEURO-ONCOLOGY BRANCH (NOB) NATURAL HISTORY STUDY (NHS) Neuro-Oncology. 20: vi115-vi115. DOI: 10.1093/Neuonc/Noy148.480  0.383
2012 Aboud O, Mrak RE, Boop F, Griffin ST. Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience. Bmc Medicine. 10: 35. PMID 22502727 DOI: 10.1186/1741-7015-10-35  0.474
Show low-probability matches.